Free Newsletter
Mayo teams with Arizona State on cancer vaccines
Arizona State University's Biodesign Institute is teaming with researchers at the Mayo Clinic to develop new cancer vaccines. Their approach will be to identify components in the cancer that can be protected against, while looking for vaccines that can have broad utility against a variety of cancers. Common themes in protein signatures produced by cancer tumors.
"This idea of identifying signatures unique to cancer suggests the possibility of preventive vaccines," said Laurence Miller, M.D., director of research and deputy director of the Mayo Clinic Cancer Center. "This approach could avoid many of the problems associated with trying to treat an established tumor."
- check out the release
Related Articles:
Teen vaccine market poised for growth. Report
vaccine market to soar. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
